PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 13 filers reported holding PTC THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,677,487,000 | -13.6% | 9,300,000 | -17.7% | 0.01% | -30.0% |
| Q4 2018 | $11,200,153,000 | -14.8% | 11,300,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $13,148,003,000 | +4.0% | 11,300,000 | -11.7% | 0.01% | 0.0% |
| Q2 2018 | $12,647,487,000 | +7.3% | 12,800,000 | 0.0% | 0.01% | +11.1% |
| Q1 2018 | $11,782,707,000 | +3.2% | 12,800,000 | -13.5% | 0.01% | -10.0% |
| Q4 2017 | $11,418,792,000 | -3.9% | 14,800,000 | 0.0% | 0.01% | -9.1% |
| Q3 2017 | $11,879,960,000 | -3.0% | 14,800,000 | -6.3% | 0.01% | -8.3% |
| Q2 2017 | $12,250,372,000 | +20.2% | 15,800,000 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $10,191,632,000 | +98094.7% | 15,800,000 | -6.0% | 0.01% | -16.7% |
| Q4 2016 | $10,379,000 | +10.6% | 16,800,000 | 0.0% | 0.01% | +20.0% |
| Q3 2016 | $9,385,000 | – | 16,800,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 23,067,000 | $26,578,000 | 21.23% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,007,000 | $15,034,000 | 0.18% |
| OAKTREE CAPITAL MANAGEMENT LP | 8,200,000 | $9,454,000 | 0.13% |
| FARALLON CAPITAL MANAGEMENT LLC | 18,350,000 | $21,114,000 | 0.12% |
| GAM Holding AG | 1,000,000 | $1,154,000 | 0.04% |
| Allianz Asset Management GmbH | 28,025,000 | $32,702,000 | 0.03% |
| LINDEN ADVISORS LP | 500,000 | $576,000 | 0.02% |
| CREDIT SUISSE AG/ | 13,362,000 | $15,307,000 | 0.01% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 11,300,000 | $13,148,003,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 15,498,000 | $17,754,000 | 0.01% |